Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6539
    +0.0015 (+0.24%)
     
  • OIL

    84.04
    +0.47 (+0.56%)
     
  • GOLD

    2,359.40
    +16.90 (+0.72%)
     
  • Bitcoin AUD

    98,149.58
    +796.38 (+0.82%)
     
  • CMC Crypto 200

    1,384.39
    -12.15 (-0.87%)
     
  • AUD/EUR

    0.6091
    +0.0018 (+0.29%)
     
  • AUD/NZD

    1.0985
    +0.0028 (+0.25%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,113.99
    +35.13 (+0.43%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,049.72
    +132.44 (+0.74%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Company News For Jan 8, 2020

  • Shares of Cellect Biotechnology Ltd. APOP surged 70.4% after the company received "Intention to Grant" patents from European and Israeli patent offices.

  • Shares of Apache Corporation APA gained 26.8% after the company, with Total SA, said it had discovered considerable oil volumes at the Maka Central-1 well drilled offshore Suriname.

  • Shares of Microchip Technology Incorporated MCHP gained 6.7% after the company raised its Q3 fiscal 2020 consolidated net sales guidance from $1.244-$1.298 billion to $1.281 billion-$1.288 billion.

  • Shares of CTI Industries Corporation CTIB declined 30% after the company executed a non-binding letter of intent to divest its subsidiary in Guadalajara, Mexico for about $4 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Apache Corporation (APA) : Free Stock Analysis Report
 
CTI Industries Corporation (CTIB) : Free Stock Analysis Report
 
Microchip Technology Incorporated (MCHP) : Free Stock Analysis Report
 
Cellect Biotechnology Ltd. (APOP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.